Copyright Reports & Markets. All rights reserved.

Global Tyrosine Kinase Inhibitors Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Tyrosine Kinase Inhibitors Market Overview

      • 1.1 Product Overview and Scope of Tyrosine Kinase Inhibitors
      • 1.2 Tyrosine Kinase Inhibitors Segment by Type
        • 1.2.1 Global Tyrosine Kinase Inhibitors Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 BCR-ABL Tyrosine Kinase Inhibitor
        • 1.2.3 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
        • 1.2.4 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
      • 1.3 Tyrosine Kinase Inhibitors Segment by Application
        • 1.3.1 Tyrosine Kinase Inhibitors Consumption Comparison by Application (2014-2025)
        • 1.3.2 Chronic Myeloid Leukemia (CML)
        • 1.3.3 Lung Cancer
        • 1.3.4 Breast Cancer
        • 1.3.5 Renal Cell Cancer
        • 1.3.6 Others
      • 1.4 Global Tyrosine Kinase Inhibitors Market by Region
        • 1.4.1 Global Tyrosine Kinase Inhibitors Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Tyrosine Kinase Inhibitors Market Size
        • 1.5.1 Global Tyrosine Kinase Inhibitors Revenue (2014-2025)
        • 1.5.2 Global Tyrosine Kinase Inhibitors Production (2014-2025)

      2 Global Tyrosine Kinase Inhibitors Market Competition by Manufacturers

      • 2.1 Global Tyrosine Kinase Inhibitors Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Tyrosine Kinase Inhibitors Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Tyrosine Kinase Inhibitors Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Tyrosine Kinase Inhibitors Production Sites, Area Served, Product Types
      • 2.5 Tyrosine Kinase Inhibitors Market Competitive Situation and Trends
        • 2.5.1 Tyrosine Kinase Inhibitors Market Concentration Rate
        • 2.5.2 Tyrosine Kinase Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Tyrosine Kinase Inhibitors Production Market Share by Regions

      • 3.1 Global Tyrosine Kinase Inhibitors Production Market Share by Regions
      • 3.2 Global Tyrosine Kinase Inhibitors Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Tyrosine Kinase Inhibitors Production
        • 3.4.1 North America Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
        • 3.4.2 North America Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Tyrosine Kinase Inhibitors Production
        • 3.5.1 Europe Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
        • 3.5.2 Europe Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Tyrosine Kinase Inhibitors Production (2014-2019)
        • 3.6.1 China Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
        • 3.6.2 China Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Tyrosine Kinase Inhibitors Production (2014-2019)
        • 3.7.1 Japan Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
        • 3.7.2 Japan Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Tyrosine Kinase Inhibitors Consumption by Regions

      • 4.1 Global Tyrosine Kinase Inhibitors Consumption by Regions
      • 4.2 North America Tyrosine Kinase Inhibitors Consumption (2014-2019)
      • 4.3 Europe Tyrosine Kinase Inhibitors Consumption (2014-2019)
      • 4.4 China Tyrosine Kinase Inhibitors Consumption (2014-2019)
      • 4.5 Japan Tyrosine Kinase Inhibitors Consumption (2014-2019)

      5 Global Tyrosine Kinase Inhibitors Production, Revenue, Price Trend by Type

      • 5.1 Global Tyrosine Kinase Inhibitors Production Market Share by Type (2014-2019)
      • 5.2 Global Tyrosine Kinase Inhibitors Revenue Market Share by Type (2014-2019)
      • 5.3 Global Tyrosine Kinase Inhibitors Price by Type (2014-2019)
      • 5.4 Global Tyrosine Kinase Inhibitors Production Growth by Type (2014-2019)

      6 Global Tyrosine Kinase Inhibitors Market Analysis by Applications

      • 6.1 Global Tyrosine Kinase Inhibitors Consumption Market Share by Application (2014-2019)
      • 6.2 Global Tyrosine Kinase Inhibitors Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Tyrosine Kinase Inhibitors Business

      • 7.1 AstraZeneca
        • 7.1.1 AstraZeneca Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.1.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.1.3 AstraZeneca Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pfizer
        • 7.2.1 Pfizer Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.2.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.2.3 Pfizer Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Novartis
        • 7.3.1 Novartis Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.3.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.3.3 Novartis Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Bristol-Myers Squibb
        • 7.4.1 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.4.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.4.3 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Bayer
        • 7.5.1 Bayer Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.5.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.5.3 Bayer Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Boehringer Ingelheim International
        • 7.6.1 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.6.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.6.3 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 F. Hoffmann-La Roche
        • 7.7.1 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.7.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.7.3 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Johnson & Johnson
        • 7.8.1 Johnson & Johnson Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.8.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.8.3 Johnson & Johnson Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Eisai
        • 7.9.1 Eisai Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 7.9.2 Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
        • 7.9.3 Eisai Tyrosine Kinase Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Tyrosine Kinase Inhibitors Manufacturing Cost Analysis

      • 8.1 Tyrosine Kinase Inhibitors Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Tyrosine Kinase Inhibitors
      • 8.4 Tyrosine Kinase Inhibitors Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Tyrosine Kinase Inhibitors Distributors List
      • 9.3 Tyrosine Kinase Inhibitors Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Tyrosine Kinase Inhibitors Market Forecast

      • 11.1 Global Tyrosine Kinase Inhibitors Production, Revenue Forecast
        • 11.1.1 Global Tyrosine Kinase Inhibitors Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Tyrosine Kinase Inhibitors Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Tyrosine Kinase Inhibitors Price and Trend Forecast (2019-2025)
      • 11.2 Global Tyrosine Kinase Inhibitors Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Tyrosine Kinase Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Tyrosine Kinase Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Tyrosine Kinase Inhibitors Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Tyrosine Kinase Inhibitors Production, Revenue Forecast (2019-2025)
      • 11.3 Global Tyrosine Kinase Inhibitors Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Tyrosine Kinase Inhibitors Consumption Forecast (2019-2025)
        • 11.3.2 Europe Tyrosine Kinase Inhibitors Consumption Forecast (2019-2025)
        • 11.3.3 China Tyrosine Kinase Inhibitors Consumption Forecast (2019-2025)
        • 11.3.4 Japan Tyrosine Kinase Inhibitors Consumption Forecast (2019-2025)
      • 11.4 Global Tyrosine Kinase Inhibitors Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Tyrosine Kinase Inhibitors Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.
        The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe.

        The global Tyrosine Kinase Inhibitors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Kinase Inhibitors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AstraZeneca
        Pfizer
        Novartis
        Bristol-Myers Squibb
        Bayer
        Boehringer Ingelheim International
        F. Hoffmann-La Roche
        Johnson & Johnson
        Eisai

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        BCR-ABL Tyrosine Kinase Inhibitor
        Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
        Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

        Segment by Application
        Chronic Myeloid Leukemia (CML)
        Lung Cancer
        Breast Cancer
        Renal Cell Cancer
        Others

        Buy now